AXSOME THERAPEUTICS INC (AXSM:NASDAQ)
$255.17 1.4 (0.5517%)
Analysed AXSOME THERAPEUTICS INC (AXSM:NASDAQ) News Sources
Axsome Therapeutics Announces Settlement Resolving All SUNOSI® (solriamfetol) Patent Litigation
03-06-2026
yahoo.com
Why Is Axsome (AXSM) Down 0.4% Since Last Earnings Report?
03-06-2026
yahoo.com
Otsuka showcases kidney drug data; Pfizer cuts an AI deal
04-06-2026
biopharmadive.com
Axsome Therapeutics Presents New SYMBRAVO® Data at the Americal Headache Society (AHS) 68th Annual Scientific Meeting
04-06-2026
yahoo.com
Why Is Ocugen (OCGN) Down 10.7% Since Last Earnings Report?
04-06-2026
yahoo.com
Why Is Mirum Pharmaceuticals (MIRM) Down 10.1% Since Last Earnings Report?
05-06-2026
yahoo.com
Does SUNOSI Patent Peace And New Migraine Data Change The Bull Case For Axsome Therapeutics (AXSM)?
05-06-2026
yahoo.com
Axsome Therapeutics Readies Auvelity Alzheimer’s Agitation Launch, Expands CNS Pipeline
06-06-2026
marketbeat.com
Agitation in Alzheimer's Disease Market to Register Immense Growth at a CAGR of 14.9% During the Forecast Period (2026-2036) | DelveInsight
11-06-2026
yahoo.com
Rapport ‘fully prepared’ to launch seizure drug solo, CEO says
12-06-2026
biopharmadive.com
What is the current price of AXSOME THERAPEUTICS INC (AXSM:NASDAQ)?
The current price of AXSOME THERAPEUTICS INC (AXSM:NASDAQ) is $255.17.
AXSOME THERAPEUTICS INC (AXSM:NASDAQ) absolute price change since previous trading day?
The absolute price change of AXSOME THERAPEUTICS INC (AXSM:NASDAQ) since the previous trading day is $1.4.
AXSOME THERAPEUTICS INC (AXSM:NASDAQ) percentage price change since previous trading day?
The percentage price change of AXSOME THERAPEUTICS INC (AXSM:NASDAQ) since the previous trading day is 0.5517%.
What is the most recent average sentiment score for AXSOME THERAPEUTICS INC (AXSM:NASDAQ)?
The most recent average sentiment score for AXSOME THERAPEUTICS INC (AXSM:NASDAQ) is 56 out of 100.
What is the most recent average sentiment for AXSOME THERAPEUTICS INC (AXSM:NASDAQ)?
The most recent sentiment for AXSOME THERAPEUTICS INC (AXSM:NASDAQ) is .
SEC-8K** Filing Available For AXSOME THERAPEUTICS INC (AXSM:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.